ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI STRAP Grants Aim To Move Research Quickly To Clinical Trials

October 1, 2010

Dinner To Raise Funds For NIH Children’s Inn

March 31, 1989

Arizona Cancer Center Wins Core Grant Renewal

June 26, 2009

Surgeons, Intramural Scientists Concerned About Representation

November 26, 1976

Cooperation Is ACS Theme For ‘90s; Dodd

February 1, 1991

SAIC-Frederick Makes Awards To Proteomics Research Teams.

January 14, 2005